Carmot plans to release preliminary Phase 1b data in type 2 diabetes in the second half of next year. Carmot can boast of one FDA-approved molecule discovered with its technology. Under a partnership with Amgen, Chemotype Evolution led to the discovery of sotorasib, brand name Lumakras, the...
The complementary use of GCM and GLP-1 medications is also endorsed by healthcare professionals such as Dr. Eden Miller, CEO of Diabetes and Obesity Care in Bend, OR. “The evidence for GLP-1 therapy and its effectiveness in disease intervention is vast, but it is not being used alone,”...